Beijing Leadman Biochemistry Co.,Ltd.

SZSE:300289 Stock Report

Market Cap: CN¥3.1b

Beijing Leadman BiochemistryLtd Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure3.1yrs

Recent management updates

Recent updates

Beijing Leadman Biochemistry Co.,Ltd.'s (SZSE:300289) 44% Price Boost Is Out Of Tune With Revenues

Oct 08
Beijing Leadman Biochemistry Co.,Ltd.'s (SZSE:300289) 44% Price Boost Is Out Of Tune With Revenues

A Look At The Fair Value Of Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289)

Apr 19
A Look At The Fair Value Of Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289)

Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289) Shares Fly 27% But Investors Aren't Buying For Growth

Mar 08
Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289) Shares Fly 27% But Investors Aren't Buying For Growth

CEO

Beijing Leadman BiochemistryLtd has no CEO, or we have no data on them.

Board Members

NamePositionTenureCompensationOwnership
Yuqing Ouyang
Member of Supervisory Board5.9yrsno datano data
Ge Yang
Independent Directorless than a yearno datano data
Yunxin Zheng
Non-Independent Director3.1yrsno datano data
Yanyi Huang
Non-Independent Director3.1yrsCN¥180.00kno data
Zhiqian Zhang
Independent Director3.1yrsCN¥120.00kno data
Na An
Independent Director3.1yrsCN¥120.00kno data
Guan Yu Lin
Chairman of the Supervisory Board3.1yrsno datano data
Zi Yao
Non-Independent Directorless than a yearno datano data
Xiangguo Li
Non-Independent Directorless than a yearno datano data

3.1yrs

Average Tenure

41yo

Average Age

Experienced Board: 300289's board of directors are considered experienced (3.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 13:50
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Beijing Leadman Biochemistry Co.,Ltd. is covered by 14 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.
Shanshan LiChina Merchants Securities Co. Ltd.
Tong ZhangChina Merchants Securities Co. Ltd.